Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

November 14, 2011

Genzyme Announces Successful Phase III Results for Alemtuzumab (CAMPATH) (LEMTRADA(TM*)) in Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
-Significant efficacy of alemtuzumab over interferon beta-1a (Rebif(R)) observed on both relapse and disability co-primary endpoints in treatment-experienced MS patients…
MS Drug Therapies

November 13, 2011

Acute Multiple Sclerosis – H.P. Acthar® Gel Reduces Shows Promise In Acute Exacerbations

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
A presentation at the American Society of Nephrology 44th Annual Meeting, showed study results of H.P. Acthar® Gel, a natural…
MS Drug Therapies

November 13, 2011

New Medication Research Study begins, to Treat Secondary Progressive MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Friday, 11 November 2011, 1:40 pm Press Release: Innate Immunotherapeutics Innate Immunotherapeutics Advances Progressive Multiple Sclerosis Study of MIS416 Auckland,…
MS Drug Therapies

November 13, 2011

An ECTRIMS (European Committee for Treatment and Research in MS) and ACTRIMS (Americas Committee for Treatment and Research in MS) WRAP-UP

  • Multiple Sclerosis
    /
  • National MS Society Related
    /
Nov 10, 2011 EXECUTIVE SUMMARY More than 7,000 investigators convened in Amsterdam on October 19-22, 2011 to present findings at…
Multiple Sclerosis

November 9, 2011

MRI Tool Helps to Predict Conversion to Pediatric MS

  • MRI
    /
  • Pediatric MS
    /
AMSTERDAM – An MRI scoring tool helped to identify children with acute central nervous system demyelination who later developed pediatric…
MRI

November 9, 2011

Progressive MS Update: Opexa’s Tovaxin(R) for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
THE WOODLANDS, Texas, Nov 08, 2011 (BUSINESS WIRE) — Opexa Therapeutics, Inc.  announced today that its lead drug candidate Tovaxin(R) has…
MS Drug Therapies

November 9, 2011

Natalizumab an Option for Pediatric MS?

  • Multiple Sclerosis
    /
  • Pediatric MS
    /
  • Tysabri
    /
November 7, 2011 (Amsterdam, the Netherlands) — A new study suggests that natalizumab (Tysabri, Biogen Idec/Elan) may be an effective…
Multiple Sclerosis

November 9, 2011

What if? Helping people achieve greater mobility

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
MOST PEOPLE THINK OF HONDA AS AN AUTO COMPANY MOST DO NOT KNOW THAT THEY ARE NOW WORKING TO HELP…
Alternative therapies and devices for Multiple Sclerosis (MS)

November 8, 2011

Recent Multiple Sclerosis Market Events Have Resulted in Treatment Modifications

  • MS Drug Therapies
    /
EXTON, Pa.–(BUSINESS WIRE)–While Biogen Idec’s Avonex and Teva’s Copaxone continue to capture the majority of multiple sclerosis (MS) patients first…
MS Drug Therapies

November 8, 2011

Saffron spice, may help protect brain cells

  • MS Research Study and Reports
    /
WASHINGTON – A key ingredient in the Indian spice saffron may potentially protect brain cells from diseases involving neuro-inflammation, such…
MS Research Study and Reports

Categories

Latest Blog Posts